澳大利亚人类遗传学会立场声明:澳大利亚的基因检测与个人保险产品
该立场声明由澳大利亚人类遗传学会于2018年更新,针对基因与基因组检测扩展及直接面向消费者的个人基因组检测增长对保险的影响。声明将适用范围扩大至不按社区风险评级的保险产品,如寿险、重症监护保险和收入保障产品。建议包括:遗传学专业教育应纳入保险歧视的伦理、法律和社会方面;澳大利亚政府应更积极监管个人保险中基因信息的使用,包括实施基因检测结果使用禁令;研究过程中获得的信息应被排除;保险业、监管机构与遗传学专业之间应加强沟通。
要点
- 澳大利亚人类遗传学会2018年更新立场声明,将保险产品范围扩大至寿险、重症监护保险和收入保障产品等不按社区风险评级的产品。
- 建议澳大利亚政府更积极监管个人保险中基因信息的使用,包括实施基因检测结果使用禁令。
- 建议在研究项目过程中获得的信息应被排除。
- 建议涉及遗传学的专业教育应将保险歧视的伦理、法律和社会方面纳入课程。
- 建议保险业、监管机构与遗传学专业之间加强沟通。
证据类型、等级与局限
- 证据类型:学会立场声明(指南/共识);原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者建议:涉及遗传学的专业教育应将保险歧视的伦理、法律和社会方面纳入课程。
- 作者建议:澳大利亚政府应更积极监管个人保险中基因信息的使用,包括实施基因检测结果使用禁令。
- 作者建议:研究项目过程中获得的信息应被排除。
- 作者建议:保险业、监管机构与遗传学专业之间应加强沟通。
指南或共识出处
- 澳大利亚人类遗传学会立场声明:澳大利亚的基因检测与个人保险产品,2018年更新。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The expansion of genetic and genomic testing in clinical practice and research and the growing market for at home personal genome testing has led to increased awareness about the impact of this form of testing on insurance. Genetic or genomic information can be requested by providers of mutually rated insurance products, who may then use it when setting premiums or determining eligibility for cover under a particular product. Australian insurers are subject to relevant legislation and an industry standard that was updated in late 2016. In 2018, the Human Genetics Society of Australasia updated its position statement on genetic testing and life insurance to account for these changes and to increase the scope of the statement to include a wider scope of insurance products that are not rated according to community risk, such as life, critical care, and income protection products. Recommendations include that providers of professional education involving genetics should include ethical, legal, and social aspects of insurance discrimination in their curricula; that the Australian government take a more active role in regulating use of genetic information in personal insurance, including enacting a moratorium on use of genetic test results; that information obtained in the course of a research project be excluded; and that there is improved engagement between the insurance industry, regulators, and the genetics profession.
参考来源
- Newson AJ, Ayres S, Boyle J, et al. Human Genetics Society of Australasia Position Statement: Genetic Testing and Personal Insurance Products in Australia. Twin Res Hum Genet. 2018. PMID: 30458892. doi:10.1017/thg.2018.60
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。